Results 161 to 170 of about 6,010 (179)

A Survey of Diagnostic Practices and the Use of Epoprostenol In Patients With Primary Pulmonary Hypertension

Chest, 1998
James Loyd, John Newman, Brian W Christman   +2 more
exaly  

Epoprostenol

Reactions Weekly, 2019
openaire   +1 more source

Epoprostenol for Treatment of Pulmonary Hypertension in Patients With Systemic Lupus Erythematosus

Chest, 2000
Robert Schilz, James Loyd, Sean Gaine
exaly  

Hemodynamics and Epoprostenol Use Are Associated With Thrombocytopenia in Pulmonary Arterial Hypertension

Chest, 2009
Kelly Chin, James de Lemos
exaly  

Integrated pharmacokinetics and pharmacodynamics of epoprostenol in healthy subjects

British Journal of Clinical Pharmacology, 2012
Andreas Krause
exaly  

Epoprostenol*

Reactions, 1985
openaire   +1 more source

Pharmacokinetic evaluation of continuous intravenous epoprostenol

Expert Opinion on Drug Metabolism and Toxicology, 2010
André Rieutord, Alice Huertas, Marie-Camille Chaumais   +2 more
exaly  

Rapid and high-dose titration of epoprostenol improves pulmonary hemodynamics and clinical outcomes in patients with idiopathic and heritable pulmonary arterial hypertension

Journal of Cardiology, 2016
Aiko Ogawa
exaly  

Epoprostenol-Induced Hypersplenism in Portopulmonary Hypertension

American Journal of the Medical Sciences, 2012
Ganesh C Kudva
exaly  

Epoprostenol

Reactions Weekly, 2000
openaire   +1 more source